 | • レポートコード：20QY06-05449 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、口唇ヘルペス（口腔ヘルペス）薬のグローバル市場について種類別（アシクロビル、バラシクロビル、ファムシクロビル、ドコサノール、その他）、用途別（外用、経口、注射）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・口唇ヘルペス（口腔ヘルペス）薬市場の概要 ・世界の主要地域別口唇ヘルペス（口腔ヘルペス）薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の口唇ヘルペス（口腔ヘルペス）薬市場規模2015-2026：種類別（アシクロビル、バラシクロビル、ファムシクロビル、ドコサノール、その他） ・世界の口唇ヘルペス（口腔ヘルペス）薬市場規模2015-2026：用途別（外用、経口、注射） ・口唇ヘルペス（口腔ヘルペス）薬の北米市場規模2015-2020 ・口唇ヘルペス（口腔ヘルペス）薬のヨーロッパ市場規模2015-2020 ・口唇ヘルペス（口腔ヘルペス）薬の中国市場規模2015-2020 ・口唇ヘルペス（口腔ヘルペス）薬の日本市場規模2015-2020 ・口唇ヘルペス（口腔ヘルペス）薬の東南アジア市場規模2015-2020 ・口唇ヘルペス（口腔ヘルペス）薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （GSK、Novartis、Teva、Mylan、Cadila、Apotex、Daewoong Pharmaceutical、Livzon、Luoxin、Med shine、Bayer (Campho Phenique)、Blistex、Kelun、Hikma、Haiwang、Carmex、Cipher） ・口唇ヘルペス（口腔ヘルペス）薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・口唇ヘルペス（口腔ヘルペス）薬の市場動向・機会・課題 ・調査の結論 |
Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.
Herpes Simplex Virus (HSV) is a commonly found human pathogen. Globally, an estimated 4.0 billion people are infected with Herpes Virus. The incidence rate of cold sores, caused by the HSV1 virus, is the second largest worldwide, trailing only behind common cold. About 79% of the US population is infected with HSV1, with about 25-35% of the adults enduring recurrent spate of cold sores. In all, close to 100 million outbreaks of cold sores occur each year in the US.
The classification of drugs for herpes labialis (oral herpes) includes valacyclovir, aciclovir, famciclovir, docosanol and other. The proportion of aciclovir in 2016 is about 17%, and the proportion of valacyclovir is about 45%.
Drugs for herpes labialis (oral herpes) are widely used though external use, oral and injection. The most proportion of drugs for herpes labialis (oral herpes) is oral, and the consumption in 2016 is about 1200 M USD.
North America is the largest consumption place, with a revenue market share nearly 36.5% in 2016. Following North America, Europe is the second largest consumption place with the revenue market share of 28.4%.
Market competition is intense. GSK, Novartis, Teva, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Drugs for Herpes Labialis (Oral Herpes) Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Drugs for Herpes Labialis (Oral Herpes) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Drugs for Herpes Labialis (Oral Herpes) industry.
Based on our recent survey, we have several different scenarios about the Drugs for Herpes Labialis (Oral Herpes) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2260.4 million in 2019. The market size of Drugs for Herpes Labialis (Oral Herpes) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Drugs for Herpes Labialis (Oral Herpes) Scope and Market Size
The global Drugs for Herpes Labialis (Oral Herpes) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drugs for Herpes Labialis (Oral Herpes) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Drugs for Herpes Labialis (Oral Herpes) market is segmented into
Aciclovir
Valacyclovir
Famciclovir
Docosanol
Other
Segment by Application, the Drugs for Herpes Labialis (Oral Herpes) market is segmented into
External Use
Oral
Injection
The Drugs for Herpes Labialis (Oral Herpes) market is analysed and market size information is provided by regions (countries). Segment by Application, the Drugs for Herpes Labialis (Oral Herpes) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Drugs for Herpes Labialis (Oral Herpes) Market Share Analysis
Drugs for Herpes Labialis (Oral Herpes) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Drugs for Herpes Labialis (Oral Herpes) business, the date to enter into the Drugs for Herpes Labialis (Oral Herpes) market, Drugs for Herpes Labialis (Oral Herpes) product introduction, recent developments, etc.
The major vendors covered:
GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer (Campho Phenique)
Blistex
Kelun
Hikma
Haiwang
Carmex
Cipher
1 Drugs for Herpes Labialis (Oral Herpes) Market Overview
1.1 Drugs for Herpes Labialis (Oral Herpes) Product Scope
1.2 Drugs for Herpes Labialis (Oral Herpes) Segment by Type
1.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2020-2026)
1.2.2 Aciclovir
1.2.3 Valacyclovir
1.2.4 Famciclovir
1.2.5 Docosanol
1.2.6 Other
1.3 Drugs for Herpes Labialis (Oral Herpes) Segment by Application
1.3.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Comparison by Application (2020-2026)
1.3.2 External Use
1.3.3 Oral
1.3.4 Injection
1.4 Drugs for Herpes Labialis (Oral Herpes) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Growth Rate (2015-2026)
1.4.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2015-2026)
1.4.3 Global Drugs for Herpes Labialis (Oral Herpes) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Drugs for Herpes Labialis (Oral Herpes) Industry Impact
1.5.1 How the Covid-19 is Affecting the Drugs for Herpes Labialis (Oral Herpes) Industry
1.5.1.1 Drugs for Herpes Labialis (Oral Herpes) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Drugs for Herpes Labialis (Oral Herpes) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Drugs for Herpes Labialis (Oral Herpes) Players to Combat Covid-19 Impact
2 Drugs for Herpes Labialis (Oral Herpes) Estimate and Forecast by Region
2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Drugs for Herpes Labialis (Oral Herpes) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Region (2015-2020)
2.2.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Region (2015-2020)
2.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Drugs for Herpes Labialis (Oral Herpes) Estimates and Projections (2015-2026)
2.4.2 Europe Drugs for Herpes Labialis (Oral Herpes) Estimates and Projections (2015-2026)
2.4.3 China Drugs for Herpes Labialis (Oral Herpes) Estimates and Projections (2015-2026)
2.4.4 Japan Drugs for Herpes Labialis (Oral Herpes) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Estimates and Projections (2015-2026)
2.4.6 India Drugs for Herpes Labialis (Oral Herpes) Estimates and Projections (2015-2026)
3 Global Drugs for Herpes Labialis (Oral Herpes) Competition Landscape by Players
3.1 Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Sales (2015-2020)
3.2 Global Top Drugs for Herpes Labialis (Oral Herpes) Players by Revenue (2015-2020)
3.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Herpes Labialis (Oral Herpes) as of 2019)
3.4 Global Drugs for Herpes Labialis (Oral Herpes) Average Price by Company (2015-2020)
3.5 Manufacturers Drugs for Herpes Labialis (Oral Herpes) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Drugs for Herpes Labialis (Oral Herpes) Players (Opinion Leaders)
4 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Type
4.1 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Review by Type (2015-2020)
4.1.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2015-2020)
4.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Type (2015-2020)
4.1.3 Global Drugs for Herpes Labialis (Oral Herpes) Price by Type (2014-2020)
4.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Forecast by Type (2021-2026)
4.2.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast by Type (2021-2026)
4.2.3 Global Drugs for Herpes Labialis (Oral Herpes) Price Forecast by Type (2021-2026)
5 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Application
5.1 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Review by Application (2015-2020)
5.1.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2015-2020)
5.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Application (2015-2020)
5.1.3 Global Drugs for Herpes Labialis (Oral Herpes) Price by Application (2015-2020)
5.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Forecast by Application (2021-2026)
5.2.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast by Application (2021-2026)
5.2.3 Global Drugs for Herpes Labialis (Oral Herpes) Price Forecast by Application (2021-2026)
3 North America Drugs for Herpes Labialis (Oral Herpes) Market Facts & Figures
3.2 North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2015-2020)
3.3 North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2015-2020)
3.4 North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2015-2020)
4 Europe Drugs for Herpes Labialis (Oral Herpes) Market Facts & Figures
4.2 Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2015-2020)
4.3 Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2015-2020)
4.4 Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2015-2020)
5 China Drugs for Herpes Labialis (Oral Herpes) Market Facts & Figures
5.2 China Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2015-2020)
5.3 China Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2015-2020)
5.4 China Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2015-2020)
6 Japan Drugs for Herpes Labialis (Oral Herpes) Market Facts & Figures
6.2 Japan Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2015-2020)
6.3 Japan Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2015-2020)
6.4 Japan Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2015-2020)
7 Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Market Facts & Figures
7.2 Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2015-2020)
8 India Drugs for Herpes Labialis (Oral Herpes) Market Facts & Figures
8.2 India Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2015-2020)
8.3 India Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2015-2020)
8.4 India Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Drugs for Herpes Labialis (Oral Herpes) Business
12.1 GSK
12.1.1 GSK Drugs for Herpes Labialis (Oral Herpes) Corporation Information
12.1.2 GSK Drugs for Herpes Labialis (Oral Herpes) Business Overview and Total Revenue
12.1.3 GSK Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GSK Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.1.5 GSK Recent Development
12.2 Novartis
12.2.1 Novartis Drugs for Herpes Labialis (Oral Herpes) Corporation Information
12.2.2 Novartis Drugs for Herpes Labialis (Oral Herpes) Business Overview and Total Revenue
12.2.3 Novartis Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.2.5 Novartis Recent Development
12.3 Teva
12.3.1 Teva Drugs for Herpes Labialis (Oral Herpes) Corporation Information
12.3.2 Teva Drugs for Herpes Labialis (Oral Herpes) Business Overview and Total Revenue
12.3.3 Teva Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Teva Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.3.5 Teva Recent Development
12.4 Mylan
12.4.1 Mylan Drugs for Herpes Labialis (Oral Herpes) Corporation Information
12.4.2 Mylan Drugs for Herpes Labialis (Oral Herpes) Business Overview and Total Revenue
12.4.3 Mylan Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Mylan Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.4.5 Mylan Recent Development
12.5 Cadila
12.5.1 Cadila Drugs for Herpes Labialis (Oral Herpes) Corporation Information
12.5.2 Cadila Drugs for Herpes Labialis (Oral Herpes) Business Overview and Total Revenue
12.5.3 Cadila Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Cadila Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.5.5 Cadila Recent Development
12.6 Apotex
12.6.1 Apotex Drugs for Herpes Labialis (Oral Herpes) Corporation Information
12.6.2 Apotex Drugs for Herpes Labialis (Oral Herpes) Business Overview and Total Revenue
12.6.3 Apotex Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Apotex Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.6.5 Apotex Recent Development
12.7 Daewoong Pharmaceutical
12.7.1 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Corporation Information
12.7.2 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Business Overview and Total Revenue
12.7.3 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.7.5 Daewoong Pharmaceutical Recent Development
12.8 Livzon
12.8.1 Livzon Drugs for Herpes Labialis (Oral Herpes) Corporation Information
12.8.2 Livzon Drugs for Herpes Labialis (Oral Herpes) Business Overview and Total Revenue
12.8.3 Livzon Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Livzon Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.8.5 Livzon Recent Development
12.9 Luoxin
12.9.1 Luoxin Drugs for Herpes Labialis (Oral Herpes) Corporation Information
12.9.2 Luoxin Drugs for Herpes Labialis (Oral Herpes) Business Overview and Total Revenue
12.9.3 Luoxin Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Luoxin Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.9.5 Luoxin Recent Development
12.10 Med shine
12.10.1 Med shine Drugs for Herpes Labialis (Oral Herpes) Corporation Information
12.10.2 Med shine Drugs for Herpes Labialis (Oral Herpes) Business Overview and Total Revenue
12.10.3 Med shine Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Med shine Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.10.5 Med shine Recent Development
12.11 Bayer (Campho Phenique)
12.11.1 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Corporation Information
12.11.2 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Business Overview and Total Revenue
12.11.3 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.11.5 Bayer (Campho Phenique) Recent Development
12.12 Blistex
12.12.1 Blistex Drugs for Herpes Labialis (Oral Herpes) Corporation Information
12.12.2 Blistex Drugs for Herpes Labialis (Oral Herpes) Business Overview and Total Revenue
12.12.3 Blistex Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Blistex Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.12.5 Blistex Recent Development
12.13 Kelun
12.13.1 Kelun Drugs for Herpes Labialis (Oral Herpes) Corporation Information
12.13.2 Kelun Drugs for Herpes Labialis (Oral Herpes) Business Overview and Total Revenue
12.13.3 Kelun Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Kelun Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.13.5 Kelun Recent Development
12.14 Hikma
12.14.1 Hikma Drugs for Herpes Labialis (Oral Herpes) Corporation Information
12.14.2 Hikma Drugs for Herpes Labialis (Oral Herpes) Business Overview and Total Revenue
12.14.3 Hikma Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Hikma Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.14.5 Hikma Recent Development
12.15 Haiwang
12.15.1 Haiwang Drugs for Herpes Labialis (Oral Herpes) Corporation Information
12.15.2 Haiwang Drugs for Herpes Labialis (Oral Herpes) Business Overview and Total Revenue
12.15.3 Haiwang Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Haiwang Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.15.5 Haiwang Recent Development
12.16 Carmex
12.16.1 Carmex Drugs for Herpes Labialis (Oral Herpes) Corporation Information
12.16.2 Carmex Drugs for Herpes Labialis (Oral Herpes) Business Overview and Total Revenue
12.16.3 Carmex Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Carmex Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.16.5 Carmex Recent Development
12.17 Cipher
12.17.1 Cipher Drugs for Herpes Labialis (Oral Herpes) Corporation Information
12.17.2 Cipher Drugs for Herpes Labialis (Oral Herpes) Business Overview and Total Revenue
12.17.3 Cipher Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Cipher Drugs for Herpes Labialis (Oral Herpes) Products Offered
12.17.5 Cipher Recent Development
13 Drugs for Herpes Labialis (Oral Herpes) Manufacturing Cost Analysis
13.1 Drugs for Herpes Labialis (Oral Herpes) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Drugs for Herpes Labialis (Oral Herpes)
13.4 Drugs for Herpes Labialis (Oral Herpes) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Drugs for Herpes Labialis (Oral Herpes) Distributors List
14.3 Drugs for Herpes Labialis (Oral Herpes) Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Drugs for Herpes Labialis (Oral Herpes) Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Drugs for Herpes Labialis (Oral Herpes) Players to Combat Covid-19 Impact
Table 8. Global Market Drugs for Herpes Labialis (Oral Herpes) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Region (2015-2020)
Table 10. Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Region (2015-2020)
Table 11. Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Region (2015-2020)
Table 13. Global Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) Forecast by Region (2021-2026)
Table 14. Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share Forecast by Region (2021-2026)
Table 17. Global Drugs for Herpes Labialis (Oral Herpes) (K MT) of Key Companies (2015-2020)
Table 18. Global Drugs for Herpes Labialis (Oral Herpes) Sales Share by Company (2015-2020)
Table 19. Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Company (2015-2020)
Table 21. Global Drugs for Herpes Labialis (Oral Herpes) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Herpes Labialis (Oral Herpes) as of 2019)
Table 22. Global Drugs for Herpes Labialis (Oral Herpes) Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Drugs for Herpes Labialis (Oral Herpes) Manufacturing Sites and Area Served
Table 24. Manufacturers Drugs for Herpes Labialis (Oral Herpes) Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Drugs for Herpes Labialis (Oral Herpes) Players
Table 27. Global Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Type (2015-2020)
Table 28. Global Drugs for Herpes Labialis (Oral Herpes) Sales Share by Type (2015-2020)
Table 29. Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Drugs for Herpes Labialis (Oral Herpes) Price (K MT) by Type (2015-2020)
Table 31. Global Drugs for Herpes Labialis (Oral Herpes) Sales Share by Type (2021-2026)
Table 32. Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Type (2021-2026)
Table 34. Global Drugs for Herpes Labialis (Oral Herpes) Price (K MT) by Type (2021-2026)
Table 35. Global Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Application (2015-2020)
Table 36. Global Drugs for Herpes Labialis (Oral Herpes) Sales Share by Application (2015-2020)
Table 37. Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Drugs for Herpes Labialis (Oral Herpes) Price (K MT) by Application (2015-2020)
Table 39. Global Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Application (2021-2026)
Table 40. Global Drugs for Herpes Labialis (Oral Herpes) Sales Share by Application (2021-2026)
Table 41. Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Application (2021-2026)
Table 43. Global Drugs for Herpes Labialis (Oral Herpes) Price (K MT) by Application (2021-2026)
Table 44. United States Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Company (2015-2020)
Table 45. United States Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2015-2020)
Table 46. United States Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Type (2015-2020)
Table 47. United States Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2015-2020)
Table 48. United States Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Application (2015-2020)
Table 49. United States Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2015-2020)
Table 50. Europe Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Company (2015-2020)
Table 51. Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2015-2020)
Table 52. Europe Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Type (2015-2020)
Table 53. Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2015-2020)
Table 54. Europe Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Application (2015-2020)
Table 55. Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2015-2020)
Table 56. China Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Company (2015-2020)
Table 57. China Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2015-2020)
Table 58. China Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Type (2015-2020)
Table 59. China Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2015-2020)
Table 60. China Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Application (2015-2020)
Table 61. China Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2015-2020)
Table 62. Japan Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Company (2015-2020)
Table 63. Japan Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2015-2020)
Table 64. Japan Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Type (2015-2020)
Table 65. Japan Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2015-2020)
Table 66. Japan Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Application (2015-2020)
Table 67. Japan Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Company (2015-2020)
Table 69. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Type (2015-2020)
Table 71. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Type (2015-2020)
Table 73. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2015-2020)
Table 74. India Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Company (2015-2020)
Table 75. India Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company (2015-2020)
Table 76. India Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Type (2015-2020)
Table 77. India Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type (2015-2020)
Table 78. India Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) by Application (2015-2020)
Table 79. India Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2015-2020)
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. GSK Drugs for Herpes Labialis (Oral Herpes) Product
Table 84. GSK Recent Development
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Novartis Drugs for Herpes Labialis (Oral Herpes) Product
Table 89. Novartis Recent Development
Table 90. Teva Corporation Information
Table 91. Teva Description and Business Overview
Table 92. Teva Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Teva Drugs for Herpes Labialis (Oral Herpes) Product
Table 94. Teva Recent Development
Table 95. Mylan Corporation Information
Table 96. Mylan Description and Business Overview
Table 97. Mylan Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Mylan Drugs for Herpes Labialis (Oral Herpes) Product
Table 99. Mylan Recent Development
Table 100. Cadila Corporation Information
Table 101. Cadila Description and Business Overview
Table 102. Cadila Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Cadila Drugs for Herpes Labialis (Oral Herpes) Product
Table 104. Cadila Recent Development
Table 105. Apotex Corporation Information
Table 106. Apotex Description and Business Overview
Table 107. Apotex Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Apotex Drugs for Herpes Labialis (Oral Herpes) Product
Table 109. Apotex Recent Development
Table 110. Daewoong Pharmaceutical Corporation Information
Table 111. Daewoong Pharmaceutical Description and Business Overview
Table 112. Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product
Table 114. Daewoong Pharmaceutical Recent Development
Table 115. Livzon Corporation Information
Table 116. Livzon Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Livzon Description and Business Overview
Table 118. Livzon Drugs for Herpes Labialis (Oral Herpes) Product
Table 119. Livzon Recent Development
Table 120. Luoxin Corporation Information
Table 121. Luoxin Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Luoxin Description and Business Overview
Table 123. Luoxin Drugs for Herpes Labialis (Oral Herpes) Product
Table 124. Luoxin Recent Development
Table 125. Med shine Corporation Information
Table 126. Med shine Description and Business Overview
Table 127. Med shine Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Med shine Drugs for Herpes Labialis (Oral Herpes) Product
Table 129. Med shine Recent Development
Table 130. Bayer (Campho Phenique) Corporation Information
Table 131. Bayer (Campho Phenique) Description and Business Overview
Table 132. Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product
Table 134. Bayer (Campho Phenique) Recent Development
Table 135. Blistex Corporation Information
Table 136. Blistex Description and Business Overview
Table 137. Blistex Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Blistex Drugs for Herpes Labialis (Oral Herpes) Product
Table 139. Blistex Recent Development
Table 140. Kelun Corporation Information
Table 141. Kelun Description and Business Overview
Table 142. Kelun Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Kelun Drugs for Herpes Labialis (Oral Herpes) Product
Table 144. Kelun Recent Development
Table 145. Hikma Corporation Information
Table 146. Hikma Description and Business Overview
Table 147. Hikma Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Hikma Drugs for Herpes Labialis (Oral Herpes) Product
Table 149. Hikma Recent Development
Table 150. Haiwang Corporation Information
Table 151. Haiwang Description and Business Overview
Table 152. Haiwang Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Haiwang Drugs for Herpes Labialis (Oral Herpes) Product
Table 154. Haiwang Recent Development
Table 155. Carmex Corporation Information
Table 156. Carmex Description and Business Overview
Table 157. Carmex Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Carmex Drugs for Herpes Labialis (Oral Herpes) Product
Table 159. Carmex Recent Development
Table . Cipher Corporation Information
Table . Cipher Description and Business Overview
Table . Cipher Drugs for Herpes Labialis (Oral Herpes) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . Cipher Drugs for Herpes Labialis (Oral Herpes) Product
Table . Cipher Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Drugs for Herpes Labialis (Oral Herpes) Distributors List
Table 168. Drugs for Herpes Labialis (Oral Herpes) Customers List
Table 169. Market Key Trends
Table 170. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 171. Key Challenges
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Herpes Labialis (Oral Herpes) Product Picture
Figure 2. Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Drugs for Herpes Labialis (Oral Herpes) Market Share by Application in 2020 & 2026
Figure 6. External Use Examples
Figure 7. Oral Examples
Figure 8. Injection Examples
Figure 9. Global Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) Growth Rate (2015-2026)
Figure 10. Global Drugs for Herpes Labialis (Oral Herpes) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Drugs for Herpes Labialis (Oral Herpes) Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Drugs for Herpes Labialis (Oral Herpes) Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Drugs for Herpes Labialis (Oral Herpes) Sales (K MT) Growth Rate (2015-2026)
Figure 16. Europe Drugs for Herpes Labialis (Oral Herpes) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Drugs for Herpes Labialis (Oral Herpes) Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Drugs for Herpes Labialis (Oral Herpes) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Drugs for Herpes Labialis (Oral Herpes) Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Drugs for Herpes Labialis (Oral Herpes) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Drugs for Herpes Labialis (Oral Herpes) Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Drugs for Herpes Labialis (Oral Herpes) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Drugs for Herpes Labialis (Oral Herpes) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Drugs for Herpes Labialis (Oral Herpes) Players Market Share by Revenue in Drugs for Herpes Labialis (Oral Herpes) 2015 & 2019
Figure 27. Drugs for Herpes Labialis (Oral Herpes) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Type (2015-2020)
Figure 29. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Application (2015-2020)
Figure 31. Global Drugs for Herpes Labialis (Oral Herpes) Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type in 2019
Figure 33. United States Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type in 2019
Figure 34. Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company in 2019
Figure 35. Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type in 2019
Figure 36. Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application in 2019
Figure 37. China Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company in 2019
Figure 38. China Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type in 2019
Figure 39. China Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application in 2019
Figure 40. Japan Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company in 2019
Figure 41. Japan Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type in 2019
Figure 42. Japan Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application in 2019
Figure 43. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company in 2019
Figure 44. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type in 2019
Figure 45. Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application in 2019
Figure 46. India Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Company in 2019
Figure 47. India Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Type in 2019
Figure 48. India Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application in 2019
Figure 49. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Cadila Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Daewoong Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Livzon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Luoxin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Med shine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Bayer (Campho Phenique) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Blistex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Kelun Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Hikma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Haiwang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Carmex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Cipher Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Key Raw Materials Price Trend
Figure 67. Manufacturing Cost Structure of Drugs for Herpes Labialis (Oral Herpes)
Figure 68. Manufacturing Process Analysis of Drugs for Herpes Labialis (Oral Herpes)
Figure 69. Drugs for Herpes Labialis (Oral Herpes) Industrial Chain Analysis
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Figure 72. Porter's Five Forces Analysis
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
単純ヘルペスウイルス（HSV）ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Herpes Simplex Virus (HSV) Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically …- 経口薄膜薬の世界市場レポート2020 Market Analysis and Insights: Global Oral Thin Film Drugs Market The global Oral Thin Film Drugs market was valued at US$ 1975.8 million in 2019 and will reach US$ 3496.4 million by the end of 2026, growing at a CAGR of 8.4% during 2020-2026. Global Oral Thin Film Drugs Scope and Market Size The glo…
- 口腔粘膜炎薬の世界市場レポート2020 Oral mucositis is the most common complication of chemotherapy, and occurs usually in the people suffering from head and neck cancer. It causes damage to mucosal lining of the mouth which results in formation of ulcers and infections. The disease occurs usually occurs after 5 to 10 days of a chemoth…
- 口腔粘膜炎治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Drugs for Oral Mucositis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Drugs for Oral Mucos…
- 経口セファロスポリンの世界市場レポート2020 Market Analysis and Insights: Global Oral Cephalosporin Market The global Oral Cephalosporin market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Oral Cephalosporin Scope and Market Size The global Oral Cephal…